Your Messages Inbox
Your Article Summary
See Latest ArticlesMedtronic Announces FDA Approval and Market Availability of Sprint Quattro Secure S Single Coil Defibrillation Lead
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/04/08
Medtronic, Inc. announced U.S. Food and Drug Administration (FDA) approval of the Medtronic Sprint Quattro Secure S single coil defibrillation lead (Model 6935) for use with implantable defibrillators in patients at risk for dangerous tachyarrhythmias (fast heartbeats) and sudden cardiac arrest. This new defibrillation lead is an addition to the Sprint Quattro family that is supported by more than seven years of post-market performance data. It provides an option for physicians who prefer a specific type of lead for patients with unique anatomies and is designed to help reduce tip pressure. The U.S. approval and market release of this single coil option follows its recent European approval and launch.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor